The most appropriate treatment strategy depends on each persons diagnosis, medical history, goals, and overall health rather than a one-size-fits-all protocol
Washington State Parkinsons Disease Registry
While other regions such as Europe, Asia Pacific, the Middle East & Africa, and Latin America are contributing to growth, North America continues to lead as the largest revenue generator
Athletes who use GLP-1 medications for approved medical reasons may need to take additional documentation steps, and athletes who are considering these medications for weight management without medical need should be aware that WADA continues to gather evidence on how these drugs are used and how they may influence athlete health and performance.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources